510(k) Report

510(k) · Cleared

Cleared

DeepHealth ProstateAI

K253682510(k) TraditionalCleared Apr 29, 2026159-day reviewClass II21 CFR 892.2090

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quantib B.V. · QDQ Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer

Cleared on Apr 29, 2026 as substantially equivalent to K212783 (Scanmed, LLC, 2022) after a 159-day review. Its family tree reaches back 4 generations to 2018.

Decided
Apr 29, 2026
Review
159 days
Class
Class II
Product code
QDQ
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to DEN180005 (2018). No later device cites it as a predicate yet.

  1. Root · 4 generations backDEN180005 OsteoDetectImagen Technologies, Inc. · 2018
  2. 3 generations backK181704 TransparaScreenpoint Medical B.V. · 2018
  3. 2 generations backK193229 TransparaScreenpoint Medical B.V. · 2020
  4. 1 generation backK212783 ProstatIDScanmed, LLC · 2022
  5. This deviceK253682 DeepHealth ProstateAIQuantib B.V. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN180005OsteoDetectImagen Technologies, Inc.2018—
−3K181704TransparaScreenpoint Medical B.V.2018—
−2K193229TransparaScreenpoint Medical B.V.2020—
−1K212783ProstatIDScanmed, LLC2022—
0 (this device)K253682DeepHealth ProstateAIQuantib B.V.2026—
FIG. 1 — Lineage of K253682, 2018–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QDQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QDQ device

  1. #1 K241831 Transpara (2.1.0)score 15.6 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K212783ProstatID
Summary page 6
…ssisted detection and diagnosis software (21 CFR 892.2090) Regulation Class: II Product Code: QDQ 3. Predicate Device Trade Name of Device: ProstatID (K212783) Common or Usual Name: ProstatIDTM MRI Diagnostic Aid for Prostate Cancer Classification Names: Radiological Computer Assisted…
Scanmed, LLC2022—

Also cleared against K212783: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 4 companies; a new generation was cleared every 2.3 years on median.
  • None of the 4 ancestors has a recall.
  • 1 other device also cites its predicate K212783.

How does its category compare?

All QDQ devices

QDQ Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · QDQ

10so far in 2026, the most since 2007

2018: 22019: 22020: 32021: 52022: 42023: 22024: 72025: 52026 (partial year): 10
2007high 10 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QDQ

216in 2025

2020: 173 days median2021: 169 days median2022: 131 days median2024: 153 days median2025: 216 days median2026 (partial year): 154 days median
2007high 216 (2025) · low 131 (2022)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QDQ

No recall names QDQ since 2007.

Adverse event reports per year · QDQ

No MAUDE report names QDQ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20182—00
20192—00
2020317300
2021516900
2022413100
20232—00
2024715300
2025521600
2026101540—

What is it indicated for?

DeepHealth ProstateAI is a Computer-Aided Detection and Diagnosis (CADe/x) software device developed to aid trained physicians in the detection and characterization of prostate cancer lesions using MR imaging data in patients aged 40 years and older. DeepHealth ProstateAI analyzes T2W, ADC and DWI MR images. Combined with the MR images the software requires a binary mask containing the prostate gland segmentation. Output consists of ROI candidates…

Read the full statement (185 words)

DeepHealth ProstateAI is a Computer-Aided Detection and Diagnosis (CADe/x) software device developed to aid trained physicians in the detection and characterization of prostate cancer lesions using MR imaging data in patients aged 40 years and older. DeepHealth ProstateAI analyzes T2W, ADC and DWI MR images. Combined with the MR images the software requires a binary mask containing the prostate gland segmentation. Output consists of ROI candidates including segmentations, and per ROI a classification indicating the likelihood of prostate cancer. The device is intended to assist in the detection of prostate cancer across the full range of grade groups (ISUP Grade Group ≥ 1), including clinically significant prostate cancer (ISUP Grade Group ≥ 2). Device outputs shall be input for a visualization and adaptation tool. DeepHealth ProstateAI is intended to be used as a concurrent reading aid for physicians assessing prostate MRI exams. Analysis by DeepHealth ProstateAI is not intended as a replacement for interpreting prostate abnormalities using MR image data consistent with clinical recommendations (e.g., including DCE information when available); nor should patient management decisions be made solely based on the results of DeepHealth ProstateAI.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K253682: DeepHealth ProstateAI.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K253682

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026